Perinatal outcomes and offspring growth profiles in twin pregnancies complicated by gestational diabetes mellitus: A longitudinal cohort study

Youwen Mei,Jiaxiao Yu,Li Wen,Xin Fan,Yan Zhao,Jie Li,Juan Qiao,Huijia Fu,Pamela Leong,Richard Saffery,Qi Tong,Mark D Kilby,Hongbo Qi,Chao Tong,Philip N Baker,Mark D. Kilby,Philip N. Baker
DOI: https://doi.org/10.1016/j.diabres.2020.108623
IF: 8.18
2021-01-01
Diabetes Research and Clinical Practice
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aims</h3><p>To evaluate the influence of gestational diabetes mellitus (GDM) on the perinatal outcomes of twin pregnancies and its impact on fetal growth profiles of twin offspring from 6 weeks to 12 months of corrected age.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>A longitudinal cohort study was conducted among pregnant women with twins and their twin offspring. All information on perinatal outcomes and child growth trajectories from 6 weeks to 12 months of corrected age were obtained and analyzed using a general linear model and logistic regression models.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>GDM was not correlated with adverse perinatal outcomes of twin pregnancies; however, in monochorionic diamniotic (MCDA), but not dichorionic diamniotic (DCDA) twin pregnancies, GDM was correlated with gestational hypertension disorder and a fetus being small for gestational age (OR, 2.68; 95% CI 1.16-6.04 and OR, 0.35; 95% CI 0.16-0.76, respectively). In both MCDA and DCDA groups, GDM was positively associated with a higher risk of childhood overweight at 6 months of corrected age (2.32 [1.05, 5.09] and 2.00 [1.13, 3.53]).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>GDM had a greater impact on MCDA twin pregnancies in terms of maternal gestational hypertension disease and small for gestational age of newborns. Additionally, twin offspring exposed to GDM had a higher risk of being overweight at 6 months of corrected age irrespective of chorionicity.</p><p><strong>Clinical Trial Registration:</strong> ChiCTR-OOC-16008203.</p>
endocrinology & metabolism
What problem does this paper attempt to address?